Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention-Reference-Cited by-同舟云学术

Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention

Published:2016-05 Issue:5 Volume:46 Page:559-565
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Intern Med J

Author:

Yudi M. B.¹²,Clark D. J.¹²,Farouque O.¹²,Eccleston D.³,Andrianopoulos N.⁴,Duffy S. J.⁴⁵,Brennan A.⁴,Lefkovits J.³,Ramchand J.¹,Yip T.⁶,Oqueli E.⁷,Reid C. M.⁴⁸,Ajani A. E.²³⁴,

Affiliation:

1. Department of Cardiology; Austin Health; Melbourne Victoria Australia

2. The University of Melbourne; Melbourne Victoria Australia

3. Department of Cardiology; Royal Melbourne Hospital; Melbourne Victoria Australia

4. Centre of Cardiovascular Research and Education in Therapeutics (CCRE); Monash University; Melbourne Victoria Australia

5. Department of Cardiology; Alfred Hospital; Melbourne Victoria Australia

6. Department of Cardiology; Geelong University Hospital; Geelong Victoria Australia

7. Department of Cardiology; Ballarat Base Hospital; Ballarat Victoria Australia

8. School of Public Health; Curtin University; Perth Western Australia Australia

Funder

Abbott

Astra-Zeneca

Biotronik

Boston Scientific

Bristol-Myers Squibb

Cordis Johnson & Johnson

CSL

Medtronic

MSD

Pfizer

Sanofi-Aventis

Servier

Schering-Plough

The Medicines Company

Publisher

Wiley

Subject

Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/imj.13041/fullpdf

Reference24 articles.

1. 2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Jneid;J Am Coll Cardiol,2012

2. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines;O'Gara;J Am Coll Cardiol,2013

3. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation;The Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC);Eur Heart J,2012

4. ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation;The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC);Eur Heart J,2011

5. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation;Sabatine;N Engl J Med,2005

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Discharge of Acute Coronary Syndrome Patients on Sub-Optimal Dual Anti-Platelet Therapy: A Single Center Experience;2023-10-19

2. Comparison of P2Y12 Inhibitors in Acute Coronary Syndromes in the Australian Population;Heart, Lung and Circulation;2022-08

3. Comparison of Clinical Outcomes Between Ticagrelor and Clopidogrel in Acute Coronary Syndrome: A Comprehensive Meta-Analysis;Frontiers in Cardiovascular Medicine;2022-01-27

4. Ticagrelor versus prasugrel in patients with acute myocardial infarction;International Journal of Cardiology;2021-12

5. Clopidogrel in noncarriers of CYP2C19 loss-of-function alleles versus ticagrelor in elderly patients with acute coronary syndrome: A pre-specified sub analysis from the POPular Genetics and POPular Age trials CYP2C19 alleles in elderly patients;International Journal of Cardiology;2021-07